C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/27/2002	WO2001094587A3 Extracellular messengers
12/27/2002	WO2001091699A3 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
12/27/2002	WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg)
12/27/2002	WO2001085937A3 Regulator of g protein signalling (rgs8)
12/27/2002	WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
12/27/2002	WO2001081404A3 INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF
12/27/2002	WO2001079441A9 Gene inactivation by targeted dna methylation
12/27/2002	WO2001077348A8 Ketogulonigenium endogenous plasmids
12/27/2002	WO2001075180A9 Sequence-dependent gene sorting techniques
12/27/2002	WO2001075131A9 Expression of uncoupling protein (ucp) in plants
12/27/2002	WO2001075119A9 21509 and 33770, novel human dehydrogenase family members and uses thereof
12/27/2002	WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002	WO2001074861A9 Compositions and methods for tissue specific gene regulation therapy
12/27/2002	WO2001070812A3 Regulation of human histamine h2-like g protein-coupled receptor
12/27/2002	WO2001067103A9 Function homology screening
12/27/2002	WO2001064956A3 The identification and use of effectors and allosteric molecules for the alteration of gene expression
12/27/2002	WO2001064952A3 Method for reducing artifacts in nucleic acid amplification
12/27/2002	WO2001057217A9 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
12/27/2002	WO2001052904A9 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides
12/27/2002	WO2001011028A9 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof
12/27/2002	WO2000052184A9 Anti-neoplastic compositions and uses thereof
12/27/2002	CA2753372A1 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
12/27/2002	CA2680376A1 Flax (linum usitatissimum l.) seed-specific promoters
12/27/2002	CA2465075A1 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002	CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002	CA2455254A1 Moraxella (branhamella) catarrhalis antigens
12/27/2002	CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells
12/27/2002	CA2451863A1 Method for transformation of mono- and di- cotyledonous plants using meristematic tissue and nodal callus from dycotiledonous plants
12/27/2002	CA2451524A1 Templated molecules and methods for using such molecules
12/27/2002	CA2451465A1 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002	CA2451074A1 Diagnosis and prognosis of breast cancer patients
12/27/2002	CA2451067A1 Method for the specific fast detection of bacteria which is harmful to beer
12/27/2002	CA2451062A1 Optimisation of synthetic catalysts by means of directed evolution
12/27/2002	CA2451053A1 Method for specific fast detection of relevant bacteria in drinking water
12/27/2002	CA2450847A1 Novel compositions
12/27/2002	CA2450845A1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
12/27/2002	CA2450831A1 Nucleic acid multiplex formation
12/27/2002	CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions
12/27/2002	CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002	CA2450732A1 Stabilized proteins with engineered disulfide bonds
12/27/2002	CA2450700A1 Trx1 antibody and uses therefor
12/27/2002	CA2450678A1 Novel polypeptide and use thereof
12/27/2002	CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002	CA2450652A1 Methods for cloning mammals using remodeling factors
12/27/2002	CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002	CA2450442A1 Novel ligand and dna thereof
12/27/2002	CA2450288A1 Novel human transporter proteins and polynucleotides encoding the same
12/27/2002	CA2450164A1 Virus detection method, primers therefor and screening kit
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2449911A1 Amplifiable probe
12/27/2002	CA2449909A1 Male contraceptives
12/27/2002	CA2449839A1 Real happy mapping
12/27/2002	CA2449366A1 Happier mapping
12/27/2002	CA2448971A1 Chimeric flavivirus vectors
12/27/2002	CA2448872A1 Peptides involved in the transmission of prionization between heterogenous erf3 proteins
12/27/2002	CA2448506A1 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002	CA2448501A1 Flax (linum usitatissimum l.) seed-specific promoters
12/27/2002	CA2448284A1 Gene expression during meningococcus adhesion
12/27/2002	CA2446468A1 Selective gene amplification
12/27/2002	CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002	CA2446284A1 Method for identification of agents for the treatment of diabetes
12/27/2002	CA2445731A1 Method and nucleic acids for the differentiation of prostate tumors
12/27/2002	CA2445261A1 Human tachykinin-related splice variants and compositions thereof
12/27/2002	CA2435151A1 Method for treating psoriasis
12/27/2002	CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/26/2002	US20020199219 Modulation of abscisic acid signal transduction in plants
12/26/2002	US20020199218 Generation of transgenic plants; obtain plant, transform with vector containing preferential protein, recover transgenic plant
12/26/2002	US20020199217 Plant sugar transport proteins
12/26/2002	US20020199216 Use of transposable elements for altering gene expression
12/26/2002	US20020199215 Protein for use as tool in biological pest control and generation of disease resistant plants
12/26/2002	US20020199214 Avian lysozyme promoter
12/26/2002	US20020199213 Transgenic transchromosomal rodents for making human antibodies
12/26/2002	US20020198509 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
12/26/2002	US20020198372 Methods for purifying nucleic acids
12/26/2002	US20020198368 Novel G protein-coupled receptors
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020198365 Antibody for use in prevention of prokaryote infections
12/26/2002	US20020198364 Protein for use in controlling reproduction and fertility in humans
12/26/2002	US20020198363 Generation of antithrombic protein; obtain nucleotide sequences coding antithrombic protein, transform microorganism, express nucleotide sequences, recover protein
12/26/2002	US20020198362 Peptide or polypeptide for use in the diagnosis, prevention and treatment of blood disorders and leukemias
12/26/2002	US20020198211 cDNA for human methylenetetrahydrofolate reductase and uses thereof
12/26/2002	US20020198168 Vaccine against Mycobacterial infections
12/26/2002	US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same
12/26/2002	US20020198164 A toxin gene is expressed under the transcriptional control of a human prostate-specific transcriptional regulatory sequence
12/26/2002	US20020198162 A recombinant multivalent antigenic polypeptide containing a first antigenic determinant of a first polypeptide and atleast a second antigenic determinant from a second polypeptide
12/26/2002	US20020198151 Intracellular inhibitors of Gq protein signaling
12/26/2002	US20020198149 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides
12/26/2002	US20020198148 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides
12/26/2002	US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002	US20020197723 Assessment of cervical cells
12/26/2002	US20020197720 Transfecting of preferential cells; provide immobilized transfection complex, incubate with cells, recover transfected cells
12/26/2002	US20020197716 Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes
12/26/2002	US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression
12/26/2002	US20020197704 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
12/26/2002	US20020197700 Receptor of the EDb-fibronectin domains
12/26/2002	US20020197698 Novel amylases
12/26/2002	US20020197695 80090, 52874, 52880, 63497, and 33425 methods and compositions of human proteins and uses thereof
12/26/2002	US20020197693 Novel molecules of the card-related protein family and uses thereof
12/26/2002	US20020197690 GNK interacting amino acid decarboxylase and methods of use thereof
12/26/2002	US20020197689 Insecticidal peptides and methods for use of same

1 ... 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 ... 4023